Skip to main content
XXII
NASDAQ Trade & Services

22nd Century Q2 Revenue Falls 30% to $2.9M as Product Shift Bites

Tom Rudovsky · Reported by Reuters
More coverage: Industrial
Sentiment info
Negative
Importance info
7
Price
$4.186
Mkt Cap
$1.487M
52W Low
$3.61
52W High
$801
52W Position info
16% above low
Off High info
99% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

XXII sits 16% above its 52-week low of $3.61.

Summary

Q2 revenue dropped 30% year-over-year to $2.9 million, driven by a deliberate shift away from low-priced export customers toward higher-margin VLN products. Adjusted EBITDA loss widened to $3.5 million from $2.6 million, and net loss was $3.3 million. The company is expanding VLN retail distribution to about 5,000 outlets by year-end 2026, including new launches in California and 150 additional stores in metro New York and northern New Jersey. Management expects the natural style cigarette expansion to accelerate revenue and margin growth in H2 2026 and aims to move toward EBITDA breakeven as higher-margin revenues scale. This follows the 8-K filed earlier today with the same figures, but adds analyst context and the retail expansion targets. The one available analyst rating is 'buy' with a median price target of $2,700, though that target appears stale given the reverse split and current price of $4.31.

At the time of this announcement, XXII was trading at $4.19 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $3.61 to $801.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Nov 16, 2026, 6:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7208
Real-time Price: $0.495 info
Change: -$0.2258 (-31%) info
Market Cap: $271.683K info
XXII
Nov 16, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.690
Real-time Price: $0.495 info
Change: -$0.195 (-28%) info
Market Cap: $271.683K info
XXII
Nov 16, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.495 info
Change: -$0.2151 (-30%) info
Market Cap: $271.683K info
XXII
Nov 03, 2026, 12:35 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0565
Real-time Price: $0.495 info
Change: Reverse Stock Split info
Market Cap: $271.683K info
XXII
Nov 03, 2026, 11:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.06355
Real-time Price: $0.495 info
Change: Reverse Stock Split info
Market Cap: $271.683K info